Delivery Order SPE2DB22D2211-SPE2DB25FRUAW

Award Date 3/26/25
Potential Completion Date 3/27/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,677.21 firm fixed-price contract is for the supply of Ceftriaxone 1 GM-D5W bags, a critical medical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $2,632.77, is for the delivery of Ceftriaxone 1 GM-D5W bags, a critical antibiotic medication, to support military healthcare requirements. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 22, 2024. Amerisourcebergen, through its Corporate Office...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,418.28 firm fixed-price delivery order is for the supply of 4,567,331,582 units of ceftriaxone 2 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,842.19, is a delivery order for the supply of Ceftriaxone 1 GM-D5W bags. The contract has a period of performance through December 5, 2024 and utilizes a firm fixed-price pricing structure. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,927.13, is for the provision of Ceftriaxone 1 GM-D5W Bags, a critical pharmaceutical product used in medical treatment. The contract has a period of performance through January 29, 2025 and utilizes a Firm Fixed Price pricing structure. This Delivery Order is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ceftriaxone 1 GM-D5W Bags. The contract has a ceiling value of $10,697.53 and a completion date of November 13, 2023. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,477.10 fixed-price delivery order is for the supply of Ceftriaxone 2 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.60 Firm Fixed Price Delivery Order contract is for the supply of Ceftriaxone 1 GM-D5W Bags, a critical medical commodity. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,696.81, is for the delivery of ceftriaxone 2 GM-D5W bags, a critical medical product used in healthcare settings. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $4,165.72 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ceftriaxone 2 GM-D5W Bags, a critical medical product. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRUAW
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,166.96, is for the delivery of ceftriaxone 2 GM-D5W bags, a type of antibiotic medication. The contract has a firm fixed price pricing type and runs through March 27, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/29/25, 12:57 AM